Design of clinical trials to evaluate the efficacy of platelet transfusion:: The euroSPRITE trial for components treated with Helinx™ technology

被引:19
作者
Cazenave, JP
Davis, K
Corash, L
机构
[1] Etablissement Francais Sang, EFS Alsace, F-67085 Strasbourg, France
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[4] Cerus Corp, Concord, CA USA
关键词
D O I
10.1053/shem.2001.29500
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:46 / 54
页数:9
相关论文
共 41 条
[1]  
ASTER RH, 1987, JAMA-J AM MED ASSOC, V257, P1777
[2]  
BEUTLER E, 1993, BLOOD, V81, P1411
[3]  
BISHOP JF, 1988, BLOOD, V71, P383
[4]  
BISHOP W, 1991, AM POETRY REV, V20, P31
[5]  
CAZENAVE JP, 2001, TRANSFUS CLIN BIO S1, V8, pA132
[6]  
Corash L., 1997, Blood, V90, p267A
[7]   PLATELET TRANSFUSION THERAPY - ONE-HOUR POST-TRANSFUSION INCREMENTS ARE VALUABLE IN PREDICTING THE NEED FOR HLA-MATCHED PREPARATIONS [J].
DALY, PA ;
SCHIFFER, CA ;
AISNER, J ;
WIERNIK, PH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (05) :435-438
[8]   Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution [J].
Davis, KB ;
Slichter, SJ ;
Corash, L .
TRANSFUSION, 1999, 39 (06) :586-592
[9]   CLINICAL-EVALUATION OF THE EFFECTS OF STORAGE TIME AND IRRADIATION ON TRANSFUSED PLATELETS [J].
DUGUID, JKM ;
CARR, R ;
JENKINS, JA ;
HUTTON, JL ;
LUCAS, GF ;
DAVIES, JM .
VOX SANGUINIS, 1991, 60 (03) :151-154
[10]  
Enright H., 1997, Blood, V90, p268A